Fibrin glue improves the therapeutic effect of MSCs by sustaining survival and paracrine function

Tissue Engineering - Part A

Volumn 19, Issue 21-22, 2013, Pages 2373-2381

  Kim, Inok ^a,b   Lee, Sung Koo ^b   Yoon, Jung In ^b   Kim, Da Eun ^b   Kim, Mihyung ^b   Ha, Hunjoo ^a  

^a Ewha Womans University   (South Korea)

^b Anterogen Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELLS; FLOWCHARTING; TISSUE;

CELL DELIVERY VEHICLES; HEPATOCYTE GROWTH FACTOR; HUMAN ADIPOSE TISSUE; HUMAN DERMAL FIBROBLASTS; INFLAMMATORY CONDITIONS; MESENCHYMAL STEM CELL; TRANSFORMING GROWTH FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

CELL CULTURE;

FIBRIN GLUE; PROSTAGLANDIN E2; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADIPOSE TISSUE; CELL DEATH; CELL MIGRATION; CELL STRESS; CELL SURVIVAL; CELLULAR SECRETION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MESENCHYMAL STEM CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; SKIN FIBROBLAST; THERAPY EFFECT;

CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; FIBRIN TISSUE ADHESIVE; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84887078314     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0665     Document Type: Conference Paper

References (40)

1. Pittenger, M.F., Mackay, A.M., Beck S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999
2. da Silva Meirelles, L., Chagastelles, P.C., and Nardi, N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119, 2204, 2006
3. Kuzmina, L.A., Petinati, N.A., Parovichnikova, E.N., Lubimova, L.S., Gribanova, E.O., Gaponova, T.V., Shipounova, I.N., Zhironkina, O.A., Bigildeev, A.E., Svinareva, D.A., Drize, N.J., and Savchenko, V.G. Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease: A phase II study. Stem Cells Int 2012, 8, 2012
4. Connick, P., Kolappan, M., Crawley, C., Webber, D.J., Patani, R., Michell, A.W., Du, M.Q., Luan, S.L., Altmann, D.R., Thompson, A.J., Compston, A., Scott, M.A., Miller, D.H., and Chandran, S. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study. Lancet Neurol 11, 150, 2012
5. Orozco, L., Soler, R., Morera, C., Alberca, M., Sánchez, A., and García-Sancho, J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: A pilot study. Transplantation 92, 822, 2011
6. Jiang, R., Han, Z., Zhuo, G., Qu, X., Li, X., Wang, X., Shao, Y., Yang, S., and Han, Z.C. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: A pilot study. Front Med 5, 94, 2011
7. Zhang, Y., Wang, F., Chen, J., Ning, Z., and Yang, L. Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects. Int Orthop 36, 1079, 2012
8. Kharaziha, P., Hellstrodddddm, P.M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M.R., and Soleimani, M. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I-II clinical trial. Eur J Gastroenterol Hepatol 21, 1199, 2009
9. Baek, S.J., Kang, S.K., and Ra, J.C. In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med 43, 596, 2011
10. Ponte, A.L., Marais, E., Gallay, N., Langonné, A., Delorme, B., Hérault, O., Charbord, P., and Domenech, J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737, 2007
11. da Silva Meirelles, L., Caplan, A.I., and Nardi, N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26, 2287, 2008
12. Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M.P., Robbins, R.C., and Pelletier, M.P. Stem cell transplantation: The lung barrier. Transplant Proc 39, 573, 2007
13. Hyun, Y.Y., Kim, I.O., Kim, M.H., Nam, D.H., Lee, M.H., Kim, J.E., Song, H.K., Cha, J.J., Kang, Y.S., Lee, J.E., Kim, H.W., Han, J.Y., and Cha, D.R. Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy. Cell Transplant 21, 2425, 2012
14. Garcia-Olmo, D., Herreros, D., Pascual, I., Pascual, J.A., Del-Valle, E., Zorrilla, J., De-La-Quintana, P., Garcia-Arranz, M., and Pascual, M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase II clinical trial. Dis Colon Rectum 52, 79, 2009
15. Cho, Y.B., Lee, W.Y., Park, K.J., Kim, M., Yoo, H.W., and Yu, C.S., Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: A phase I clinical study. Cell Transplant 22, 279, 2013
16. Lee, Y.W., Park, K.J., Cho, Y.B., Yoon, S.N., Song, K.H., Kim, D.S., Jung, S.H., Kim, M., Yoo, H.W., Kim. I., Ha, H., and Yu, C.S. Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for crohn's fistula. Stem Cells 2013 [Epub ahead of print]; doi: 10.1002/stem.1357
17. Han, S.K., Kim, H.R., and Kim, W.K. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: A pilot study. Wound Repair Regen 18, 342, 2010
18. Haleem, A.M., Singergy, A.A., Sabry, D., Atta, H.M., Rashed, L.A., Chu, C.R., El Shewy, M.T., Azzam, A., and Abdel Aziz, M.T. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: A pilot study and preliminary results. Cartilage 1, 253, 2010
19. Guo, H.D., Wang, H.J., Tan, Y.Z., and Wu, J.H. Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng Part A 17, 45, 2011
20. Ho, W., Tawil, B., Dunn, J.C., and Wu, B.M. The behavior of human mesenchymal stem cells in 3D fibrin clots: Dependence on fibrinogen concentration and clot structure. Tissue Eng 12, 1587, 2006
21. Ahmed T.A., Giulivi, A., Griffith, M., and Hincke, M. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Eng Part A 17, 323, 2011
22. Zhang, X., Wang, H., Ma, X., Adila, A., Wang, B., Liu, F., Chen, B., Wang, C., and Ma, Y. Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fibrin scaffolds. Exp Biol Med (Maywood) 235, 1505, 2010
23. Wang, J., Wang, J., Liao, L., and Tan, J. Mesenchymal-stemcell-based experimental and clinical trials: Current status and open questions. Expert Opin Biol Ther 11, 893, 2011
24. Asanuma, H., Meldrum, D.R., and Meldrum, K.K. Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol 184, 26, 2010
25. Uccelli, A., Moretta, L., and Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8, 726, 2008
26. Cui, L., Yin, S., Liu, W., Li, N., Zhang, W., and Cao, Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 13, 1185, 2007
27. Girandon, L., Kregar-Velikonja, N., Božikov, K., and Barlič, A. In vitro models for adipose tissue engineering with adipose-derived stem cells using different scaffolds of natural origin. Folia Biol (Praha) 57, 47, 2011
28. Lee, H.H., Haleem, A.M., Yao, V., Li, J., Xiao, X., and Chu, C.R. Release of bioactive adeno-Associated virus from fibrin scaffolds: Effects of fibrin glue concentrations. Tissue Eng Part A 17, 1969, 2011
29. Cox, S., Cole, M., and Tawil, B. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: Dependence on fibrinogen and thrombin concentration. Tissue Eng 10, 942, 2004
30. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C.J., Bovenkerk, J.E., Pell, C.L., Johnstone, B.H., Considine, R.V., and March, K.L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292, 2004
31. Williams, A.R., and Hare, J.M. Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109, 923, 2011
32. Yoo, K.H., Jang, I.K., Lee, M.W., Kim, H.E., Yang, M.S., Eom, Y., Lee, J.E., Kim, Y.J., Yang, S.K., Jung, H.L., Sung, K.W., Kim, C.W., and Koo, H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259, 150, 2009
33. Sotiropoulou, P.A., Perez, S.A., Salagianni, M., Baxevanis, C.N., and Papamichail, M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24, 462, 2006
34. Yañez, R., Oviedo, A., Aldea, M., Bueren, J.A., and Lamana, M.L. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res 316, 3109, 2010
35. Goodwin, J.S., Bankhurst, A.D., and Messner, R.P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 146, 1719, 1977
36. Scales, W.E., Chensue, S.W., Otterness, I., and Kunkel, S.L. Regulation of monokine gene expression: Prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-Associated bioactivity. J Leukoc Biol 45, 416, 1989
37. van der Pouw Kraan, T.C., Boeije, L.C., Smeenk, R.J., Wijdenes, J., and Aarden, L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181, 775, 1995
38. Snyder, D.S., Beller, D.I., and Unanue, E.R. Prostaglandins modulate macrophage Ia expression. Nature 299, 163, 1982
39. Sotiropoulou, P.A., Perez, S.A., Gritzapis, A.D., Baxevanis, C.N., and Papamichail, M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24, 74, 2006
40. Jiang, X.X., Zhang, Y., Liu, B., Zhang, S.X., Wu, Y., Yu, X.D., and Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105, 4120, 2005